Skip to main content
Terug
Watch Compare

Corbus Pharmaceuticals Holdings, Inc.

Datakwaliteit: 83%
CRBP
Nasdaq Manufacturing Chemicals
€ 10,26
▲ € 0,42 (4,22%)
Marktkapitalisatie: 181,89 M
Prijs
€ 10,26
Marktkapitalisatie
181,89 M
Dagbereik
€ 9,81 — € 10,73
52-Weeksbereik
€ 5,32 — € 20,56
Volume
154.881
Openen € 9,82
50D / 200D Gem.
€ 8,56
19,74% above
50D / 200D Gem.
€ 10,03
2,25% above

Quick Summary

Belangrijkste Punten

Negative free cash flow of -64,50 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-77,32%
Onder sectorgemiddelde (-51,02%)
ROIC-66,01%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio6,31
Interest CoverageN/A

Waardering

PE (TTM)
-2,32
Onder sectorgemiddelde (-1,98)
P/B Ratio1,97
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (44 peers)
Metriek Aandeel Sector Mediaan
P/E -2,3 -2,0
P/B 2,0 5,1
ROE % -77,3 -51,0
Net Margin % — -150,2
Rev Growth 5Y % — 9,3
D/E — 0,3

ETFs Holding This Stock

GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0,01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -78,54 M
ROE -77,32% ROA -66,95%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -64,50 M
ROIC -66,01% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 6,31
Interest Coverage N/A Asset Turnover N/A
Working Capital 90,51 M Tangible Book Value 92,15 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,32 Forward P/E N/A
P/B Ratio 1,97 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -35,46%
Market Cap 181,89 M Enterprise Value 154,90 M
Per Share
EPS (Diluted TTM) -5,90 Revenue / Share N/A
FCF / Share -3,64 OCF / Share -3,64
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 82,12%
SBC-Adj. FCF -71,60 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — 0,0 881.705,0
Net Income -78,54 M -40,21 M -44,60 M -42,35 M -45,64 M
EPS (Diluted) -5,90 -3,68 -10,31 -10,15 —
Gross Profit — — — — —
Operating Income -85,31 M -48,72 M -45,08 M -39,84 M -55,99 M
EBITDA — — — — —
R&D Expenses 70,10 M 32,22 M 31,17 M 16,14 M 36,45 M
SG&A Expenses — — — — —
D&A 233.000,0 588.000,0 640.601,0 762.995,0 999.817,0
Interest Expense 0,0 1,80 M 3,81 M 3,10 M 2,71 M
Income Tax 0,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 168,20 M 155,88 M 28,27 M 66,31 M 107,73 M
Total Liabilities 20,69 M 13,45 M 35,18 M 33,32 M 38,62 M
Shareholders' Equity 147,50 M 142,43 M -6,90 M 32,99 M 69,11 M
Total Debt — — 17,89 M 21,59 M 21,19 M
Cash & Equivalents 28,49 M 17,20 M 13,72 M 17,00 M 25,01 M
Current Assets 166,95 M 152,98 M 23,55 M 60,18 M 100,20 M
Current Liabilities 20,69 M 11,82 M 31,89 M 12,64 M 17,01 M